Roy A. Bakay Functional Neurosurgery Lectureship Highlights

Overview

The Roy A. Bakay Functional Neurosurgery Lectureship featured discussions on pioneering work in deep brain stimulation and emerging gene therapy techniques for neurological disorders. Key advances include convection enhanced delivery and viral vector gene therapies with promising clinical trial developments.

Background

Dr. Roy A. Bakay was a pioneering neurosurgeon who contributed significantly to the development of deep brain stimulation (DBS) for movement disorders. His legacy continues through ongoing research in functional neurosurgery and restorative therapies. The lectureship highlights advances in gene therapy, including the use of viral vectors and convection enhanced delivery to treat neurological diseases. These innovations build on decades of research and clinical trials aimed at improving patient outcomes.

Data Highlights

Dr. Russ, a key presenter, has secured nearly $80 million in NIH research funding and led a $13.5 million clinical trial focused on gene therapy safety and efficacy. Gene expression from viral vector delivery has been observed for over two decades in nonhuman primates, indicating long-term treatment potential. The upcoming biological product for Parkinson's disease treatment is anticipated within 18 months.

Key Findings

• Dr. Roy A. Bakay was instrumental in initiating the first human deep brain stimulation work and was highly regarded in movement disorder neurosurgery.
• Convection enhanced delivery (CED) is a transformative technique improving targeted gene therapy delivery in the nervous system.
• Gene therapy using viral vectors provides permanent gene expression, with safety and efficacy demonstrated in long-term animal studies.
• Historical gene therapy trials faced setbacks, including immune responses and treatment failures, but advances in viral vector engineering have revitalized the field.
• Current clinical trials, supported by substantial NIH funding, are advancing gene therapy applications for Parkinson's disease and other neurological disorders.
• Collaboration between academic centers and industry is driving innovation in neurosurgical restorative therapies.

Clinical Implications

Clinicians should be aware of the evolving landscape of gene therapy and convection enhanced delivery as promising modalities for treating neurological disorders. Understanding the history and safety profile of viral vector therapies is critical for integrating these approaches into clinical practice. Ongoing clinical trials may soon provide new therapeutic options for conditions like Parkinson's disease.

Conclusion

The Roy A. Bakay Functional Neurosurgery Lectureship underscores the progress from foundational DBS work to cutting-edge gene therapy techniques. Continued research and clinical trials hold promise for transformative treatments in functional neurosurgery.

References

1. Baptist Health Miami Neuroscience Institute -- Roy A. Bakay Functional Neurosurgery Lectureship